Chinese herbal medicine as an adjunctive therapy for breast cancer: A systematic review and meta-analysis

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Zhu, Libing ^a   Li, Lingru ^a   Li, Yingshuai ^a   Wang, Ji ^a   Wang, Qi ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGELICA SINENSIS; ASTRAGALUS (PLANT); BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CHINESE MEDICINE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DISTANT METASTASIS; HERBAL MEDICINE; HUMAN; LOCAL METASTASIS; NAUSEA AND VOMITING; RADIX ASTRAGALUS; RECURRENCE RISK; REVIEW; RHIZOMA ATRACTYLODIS MACROCEPHALAE; RHIZOME; SURVIVAL RATE; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; TREATMENT RESPONSE;

EID: 84973363518     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/9469276     Document Type: Review

References (64)

1. D. M. Parkin, "Global cancer statistics in the year 2000, " The Lancet Oncology, vol. 2, no. 9, pp. 533-543, 2001.
2. R. L. Siegel, K. D. Miller, and A. Jemal, "Cancer statistics, 2016, " CA: A Cancer Journal for Clinicians, vol. 66, no. 1, pp. 7-30, 2016.
3. C. Sotiriou, S.-Y. Neo, L. M. McShane, et al., "Breast cancer classification and prognosis based on gene expression profiles from a population-based study, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 18, pp. 10393-10398, 2003.
4. T. Sorlie, C. M. Perou, R. Tibshirani, et al., "Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, " Proceedings of the National Academy of Sciences of theUnited States ofAmerica, vol. 98, no. 19, pp. 10869-10874, 2001.
5. Y. Cui, X.-O. Shu, Y. Gao, et al., "Use of complementary and alternative medicine by Chinese women with breast cancer, " Breast Cancer Research and Treatment, vol. 85, no. 3, pp. 263-270, 2004.
6. J. J. Tao, K. Visvanathan, and A. C. Wolff, "Long termside effects of adjuvant chemotherapy in patients with early breast cancer, " The Breast, vol. 24, supplement 2, pp. S149-S153, 2015.
7. A. M. Gonzalez-Angulo, F. Morales-Vasquez, and G. N. Hortobagyi, "Overview of resistance to systemic therapy in patients with breast cancer, " Advances in Experimental Medicine and Biology, vol. 608, pp. 1-22, 2007.
8. A. Molassiotis, J. A. Scott, N. Kearney, et al., "Complementary and alternative medicine use in breast cancer patients in Europe, " Supportive Care in Cancer, vol. 14, no. 3, pp. 260-267, 2006.
9. A. Molassiotis, P. Fernandez-Ortega, D. Pud, et al., "Use of complementary and alternative medicine in cancer patients: a European survey, " Annals of Oncology, vol. 16, no. 4, pp. 655-663, 2005.
10. J. Shen, R. Andersen, P. S. Albert, et al., "Use of complementary/alternative therapies by women with advanced-stage breast cancer, " BMC Complementary and Alternative Medicine, vol. 2, article 8, 2002.
11. L. M. DiGianni, J. E. Garber, and E. P. Winer, "Complementary and alternative medicine use amongwomen with breast cancer, " Journal of ClinicalOncology, vol. 20, no. 18, supplement, pp. 34s-38s, 2002.
12. J. Huebner, K. Muenstedt, F. J. Prott, et al., "Online survey of patients with breast cancer on complementary and alternative medicine, " Breast Care, vol. 9, no. 1, pp. 60-63, 2014.
13. A. Sparber, L. Bauer, G. Curt, et al., "Use of complementary medicine by adult patients participating in cancer clinical trials, " Oncology Nursing Forum, vol. 27, no. 4, pp. 623-630, 2000.
14. Z. Chen, K. Gu, Y. Zheng, W. Zheng, W. Lu, and X. O. Shu, "The use of complementary and alternative medicine among Chinese women with breast cancer, " Journal of Alternative and Complementary Medicine, vol. 14, no. 8, pp. 1049-1055, 2008.
15. W. C. S. Cho, "Scientific evidence on the supportive cancer care with chinese medicine, " Chinese Journal of Lung Cancer, vol. 13, no. 3, pp. 190-194, 2010.
16. Q. T. Chen, H. X. Zhu, Z. Q. Liu, H. B. Wang, Y. Xu, and Y. Li, "Clinical observation on the effect-enhancing and toxicityreducing efficacy of Dangguibuxue decoction for postoperative breast cancer patients with chemotoxicity, " Journal of Hebei Medical College for Continuing Education, no. 6, pp. 50-51, 2008.
17. Y. Q. Liang, W. J. Yin, W. Qian, H. L. Wang, C. Ma, and H. Y. Du, "Effects of Huaier Granule combined with systemic chemotherapy on immunologic function and prognosis for advanced breast cancer patients, " Chinese Journal of Bases and Clinics in General Surgery, no. 12, pp. 1482-1486, 2015.
18. Y. L. Du, Z. M. Wang, F. Wang, and D. Y. Lu, "Efficacy observation on modified Xiaoyao powder combined with chemotherapy for postoperative breast cancer, " Modern Journal of Integrated Traditional Chinese Medicine and Western Medicine, no. 3, pp. 295-297, 2015.
19. A. B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler, "Reporting results of cancer treatment, " Cancer, vol. 47, no. 1, pp. 207-214, 1981.
20. L. L. D. Zhong, H.-Y. Chen, W. C. S. Cho, X.-M. Meng, and Y. Tong, "Theefficacy of Chinese herbalmedicine as an adjunctive therapy for colorectal cancer: a systematic review and metaanalysis, " Complementary Therapies in Medicine, vol. 20, no. 4, pp. 240-252, 2012.
21. WHO, WHO Handbook for Reporting Results of Cancer Treatment, World Health Organization, Geneva, Switzerland, 1979.
22. J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Version 5. 1. 0, 2016.
23. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Version 5. 1. 0, 2011.
24. H. W. Li, "Self-made Fuzheng Xiaoliufang as an adjuvant therapy for advanced breast cancer and its impact on serum tumor marker, " China Pharmaceuticals, no. 3, pp. 11-13, 2015.
25. H. H. Chen, W. Wang, G. X. Shi, and J. W. Li, "Effect ofChinese herbal compound combining chemotherapy on recurrence breast cancer, " Liaoning Journal of Traditional ChineseMedicine, no. 5, pp. 1003-1005, 2015.
26. J. G. Wang, "The long-term efficacy observation on Xiaozheng compound as an adjuvant therapy for breast cancer liver metastasis, " Journal of New Chinese Medicine, no. 6, pp. 224-225, 2015.
27. L. L. Fang and Y. Jia, "Method of promoting blood circulation to remove blood stasis and detoxication combined with chemotherapy on breast cancer of intermediate stage and advanced stage, " Journal of Shanxi College of Traditional Chinese Medicine, no. 2, pp. 52-53, 2015.
28. J. W. Bai and W. M. Wu, "Efficacy analysis of Jin Long Capsule (JLC) in neoadjuvant chemotherapy of breast cancer, " Chinese Journal of Clinical Oncology, no. 4, pp. 246-249, 2014.
29. L. Guo, "Experience of 76 cases with mammary cancer treated with integrated Chinese and westernmedicine, " Clinical Journal of Chinese Medicine, no. 15, pp. 137-138, 2014.
30. F. Xie, "Clinical analysis Shenqifuzheng injection combined with chemotherpay in the treatment of breast cancer, " Guide of China Medicine, no. 30, pp. 19-20, 2014.
31. J. Yang, J. L. He, X. X. Li, and Y. H. Yang, "Analysis of curative effect of spleen and kidney strengthening herb combined with observation of 43 cases, " Guiding Journal of Traditional Chinese Medicine and Pharmacy, no. 13, pp. 33-35, 2014.
32. Y. S. Cheng, F. Y. Gong, A. W. Li, Y. S. Wen, G. J. Wang, and Y. Lv, "Modified Lizhong decoction for nausea and vomiting caused by breast cancer chemotherapy, " Journal of Sichuan of Traditional Chinese Medicine, no. 5, pp. 90-91, 2013.
33. D. J. Wang, "Clinical observation of Chinese and Western drugs for the treatment of 76 cases of breast cancer, " Medical Recapitulate, vol. 14, pp. 2676-2678, 2013.
34. L. K. Xiong, "The impact of Fuzheng Xiaoji compound combinedwith chemotherapy on the quality of life and serumtumor marker of breast cancer patients, "Yunnan Journal of Traditional Chinese Medicine, no. 4, pp. 14-15, 2012.
35. S. X. Zhang and H. Dang, "The method of Fuzheng Guben combined with NP chemotherapy for 30 cases advanced breast cancer, " Guangming Journal of Chinese Medicine, no. 5, pp. 980-982, 2012.
36. L. M. Pan, "Cinobufagin combined with chemotherapy for 160 cases advanced breast cancer, " China ForeignMedical Treatment, no. 1, pp. 59-61, 2011.
37. G. W. Yang, "Combination of the magical power of trichosanthes and chemotherapy in advanced breast cancer, " Journal of Liaoning University of TCM, no. 7, pp. 84-85, 2011.
38. Y. Cheng, "Clinical observation on Fuzheng Kanai compound combined TP for advanced breast cancer, " Medical Technology, no. 12, pp. 92-93, 2011.
39. Y. C. Zhang, X. J. Li, Y. J. Jia, J. Chen, and Y. Y. Sun, "Clinical observation of Fuzheng Quyu Jiedu Prescription combining with chemotherapy in treating postoperative breast cancer, " Shanghai Journal of Traditional ChineseMedicine, no. 11, pp. 64-66, 2011.
40. J. J. Feng, J. P. Zhao, W. K. Jia, G. Y. Zhao, and T. Peng, "Effect observation of chemotherapy with modified Wumeiwan on advanced breast cancer, " Shanxi Journal of Traditional Chinese Medicine, no. 7, pp. 33-34, 2010.
41. P. Y. Zhang, "Chinese herbal compound combined with chemotherapy for 50 cases advanced breast cancer, " Liaoning Journal of Traditional ChineseMedicine, no. 4, pp. 130-131, 2009.
42. G. W. Yang, Y. M. Xu, Q. Fu, et al., "Clinical observat ion on guben Yiliu II combined with chemotherapy in the treatment of 28 cases of advanced breast cancer, " Journal of Traditional Chinese Medicine, no. 12, pp. 1081-1083, 2008.
43. J. H. Hu, Y. F. Yuan, and J. Q. He, "Yiqihuoxue decoction combined with new adjuvant chemotherapy for 28 cases breast cancer, " Hunan Journal of Traditional Chinese Medicine, no. 2, pp. 38-39, 2008.
44. J. W. Tang, L. Li, and X. Y. Tang, "Yiqijiedu decoction combined with chemotherapy for 30 cases breast cancer (type Qi-deficiency while toxin flourishing), " Traditional Chinese Medicine Research, no. 7, pp. 28-29, 2007.
45. Z. F. Huang, J. B. Liu, Q. S. Chen, H. Z. Li, Z. J. Zhang, and C. J. Huang, "The effect of Jianpi Xiaoji decoction combined with chemotherapy for the quality of life and immunologic function of advanced breast cancer patients, " Journal of New Chinese Medicine, no. 5, pp. 88-89, 2007.
46. H. Y. Yang, C. L. Tong, and M. Huang, "Clinical observation on Taohongsiwu decoction combined with new adjuvant chemotherapy for breast cancer with stagnation of blood stasis, " Modern Journal of Integrated Traditional Chinese and Western Medicine, no. 10, pp. 1327-1328, 2007.
47. H. Dai, C. L. Zhu, and X. L. Wang, "Tiaoganyangxue decoction combined with NP chemotherapy for 25 cases advanced breast cancer, " Jilin Journal of Traditional Chinese Medicine, no. 4, pp. 33-34, 2004.
48. X. L. Li, Q. Y. Tian, and W. J. Ma, "Clinical observation on Senqifuzheng injection combined with chemotherpay for advanced breast cancer, " Modern Oncology, no. 6, pp. 574-575, 2004.
49. L. Yang and S. Sun, "Clinical research into the treatment of mammary cancer by chemotherapy combined with TCMdrugs before operation, " Journal of Hennan University of Chinese Medicine, no. 4, pp. 40-41, 2004.
50. Z. F. Huang, J. S. Wei, Z. Y. Shi, and K. Zhong, "Study of Bazhen decoction and chemotherapy on mammary cancer in metaphase or later period, " Modern Journal of Integr ated Traditional Chinese andWesternMedicine, no. 11, pp. 1123-1124, 2003.
51. T. Zhou and F. J. Zhou, "Gonghuanyangxue granule for the Qiblood-deficiency syndrome of breast cancer after new adjuvant chemotherapy, " Guiding Journal of Traditional ChineseMedicine and Pharmacy, no. 6, pp. 63-65, 2015.
52. L. F. Li and M. Han, "The effect of YIqihuoxue method as an adjuvant therapy for postoperative breast cancer and its impact on patients quality of life, " Sichuan Jouranl of Traditional Chinese Medicine, no. 3, pp. 119-121, 2015.
53. J. Liu, S. X. Wei, and M. Lu, "The observation of attenuation and synergy of postoperative chemotherapy matching with traditional Chinese drug Tianzhicao capsule in breast cancer, " Medical Journal ofWest China, no. 5, pp. 896-897, 2011.
54. C. Liu, L. Y. Wu, H. J. Zhao, and N. Yang, "Clinical observation on Rensenyangrong decoction for theQi-blood-deficiency type of breast cancer which caused by new adjuvant chemotherapy, " The Western Journal of Traditional Chinese Medicine, no. 11, pp. 8-11, 2011.
55. K. H. Chang, R. Brodie, M. A. Choong, K. J. Sweeney, and M. J. Kerin, "Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals, " BMC Cancer, vol. 11, article 196, 2011.
56. S. G. Li, H. Y. Chen, C. S. Ou-Yang, et al., "The efficacyofChinese herbal medicine as an adjunctive therapy for advanced nonsmall cell lung cancer: a systematic review and meta-analysis, " PLoS ONE, vol. 8, no. 2, Article ID e57604, 2013.
57. W. C. S. Cho and H.-Y. Chen, "Clinical efficacy of traditional Chinesemedicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis, " Cancer Investigation, vol. 27, no. 3, pp. 334-344, 2009.
58. W. C. S. Cho and H.-Y. Chen, "Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma:meta-analysis, " ExpertOpinion on Investigational Drugs, vol. 18, no. 5, pp. 617-635, 2009.
59. J. S. Yates, K. M. Mustian, G. R. Morrow, et al., "Prevalence of complementary and alternativemedicine use in cancer patients during treatment, " Supportive Care in Cancer, vol. 13, no. 10, pp. 806-811, 2005.
60. K. I. Block and M. N. Mead, "Immune system effects of echinacea, ginseng, and astragalus: a review, " Integrative Cancer Therapies, vol. 2, no. 3, pp. 247-267, 2003.
61. W. C. S. Cho and K. N. Leung, "In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus, " Journal of Ethnopharmacology, vol. 113, no. 1, pp. 132-141, 2007.
62. M. McCulloch, C. See, X.-J. Shu, et al., "Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer:meta-analysis of randomized trials, " Journal of Clinical Oncology, vol. 24, no. 3, pp. 419-430, 2006.
63. W. Kim, S.-H. Kim, S. K. Park, and M. S. Chang, "Astragalus membranaceus ameliorates reproductive toxicity induced by cyclophosphamide in male mice, " Phytotherapy Research, vol. 26, no. 9, pp. 1418-1421, 2012.
64. A. Flower, C. Witt, J. P. Liu, G. Ulrich-Merzenich, H. Yu, and G. Lewith, "Guidelines for randomised controlled trials investigating Chinese herbal medicine, " Journal of Ethnopharmacology, vol. 140, no. 3, pp. 550-554, 2012.